Artelo Biosciences ARTL
NASDAQ ARTL
$2.57 -0.05 (-1.91%)
As of: Oct 21, 2026 · 3:59 PM EDT

Artelo Biosciences (ARTL) Total Current Liabilities (2015 - 2025)

Updated

Artelo Biosciences (ARTL) recorded Total Current Liabilities of $4.04 million in Q4 2025, up 128.2% from $1.77 million a year earlier but down 16.8% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Total Current Liabilities (2015 - 2025) Analysis & Trends

Starting with Q2 2015, Artelo Biosciences' Total Current Liabilities history includes 42 quarters.

  • Annual Total Current Liabilities has increased for three straight years, with a five-year compound annual growth rate of 51.8% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $1.77 million in FY2024 (+37.3%), $1.29 million in FY2023 (+29.4%), $998,000 in FY2022 (-2.8%) and $1.03 million in FY2021.
  • Quarterly Total Current Liabilities has ranged from $423,943 in Q3 2021 to $5.71 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Total Current Liabilities has increased for five consecutive quarters, with growth averaging 197.3% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 597.3% in Q3 2025, against a decline of 24.3% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.86 million (Q3 2025), $5.71 million (Q2 2025) and $2.8 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Artelo Biosciences 52,106.49 -5.08 Mn - 4.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.04 Mn
Sep 30, 2025 4.86 Mn
Jun 30, 2025 5.71 Mn
Mar 31, 2025 2.80 Mn
Dec 31, 2024 1.77 Mn
Sep 30, 2024 697,000.00
Jun 30, 2024 940,000.00
Mar 31, 2024 721,000.00
Dec 31, 2023 1.29 Mn
Sep 30, 2023 921,000.00
Jun 30, 2023 603,000.00
Mar 31, 2023 825,000.00
Dec 31, 2022 998,000.00
Sep 30, 2022 480,000.00
Jun 30, 2022 527,000.00
Mar 31, 2022 875,000.00
Nov 30, 2021 659,000.00
Aug 31, 2021 526,000.00
May 31, 2021 423,943.00
Feb 28, 2021 588,966.00
API Access

Artelo Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ARTL&period=max&api_key=YOUR_API_KEY